Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
We investigated the role of complement component C1q in the IgG-independent opsonophagocytosis of type III group B Streptococcus (GBS) by peripheral blood leukocytes. We report that C1q binds to type III GBS both in normal human serum deficient in IgG specific for type III capsular polysaccharide and in a low-ionic strength buffer. The dissociation constant Kd ranged from 2.0 to 5.5 nM, and the number of binding sites Bmax ranged from 630 to 1360 molecules of C1q per bacterium (CFU). An acapsular mutant strain of GBS bound C1q even better than the wild type, indicating that the polysaccharide capsule is not the receptor for C1q. In serum, binding of C1q to GBS was associated with activation of the classical complement pathway. However, normal human serum retained significant opsonic activity after complete depletion of C1q, suggesting that the serum contains a molecule that is able to replace C1q in opsonization and/or complement activation. Mannan-binding lectin, known to share some functions with C1q, appeared not to be involved, since its depletion from serum had little effect on opsonic activity. Excess soluble C1q or its collagen-like fragment inhibited phagocytosis mediated by normal human serum, suggesting that C1q may compete with other opsonins for binding to receptor(s) on phagocytes. We conclude that, although C1q binds directly to GBS, C1q binding is neither necessary nor sufficient for IgG-independent opsonophagocytosis. The results raise the possibility that additional unknown serum factor(s) may contribute to opsonization of GBS directly or via a novel mechanism of complement activation.
Butko
P
P
Channing Laboratory, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA.
Nicholson-Weller
A
A
Wessels
M R
MR
D002352:Carrier Proteins / Q000097:blood; D003094:Collagen / Q000276:immunology / Q000494:pharmacology; D037222:Collectins; D015922:Complement C1q / Q000378:metabolism / Q000502:physiology*; D003171:Complement Pathway, Classical / Q000276:immunology; D006001:Glycoconjugates / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000502:physiology*; D007166:Immunosuppressive Agents / Q000276:immunology / Q000494:pharmacology; D037102:Lectins / Q000097:blood; D008351:Mannans / Q000097:blood; D009504:Neutrophils / Q000276:immunology / Q000382:microbiology; D009895:Opsonin Proteins / Q000097:blood*; D010446:Peptide Fragments / Q000276:immunology / Q000494:pharmacology; D010587:Phagocytosis / Q000276:immunology*; D011135:Polysaccharides, Bacterial / Q000276:immunology; D012995:Solubility; D013292:Streptococcus agalactiae / Q000276:immunology*
D002352:Carrier Proteins; D037222:Collectins; D006001:Glycoconjugates; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D037102:Lectins; D008351:Mannans; D009895:Opsonin Proteins; D010446:Peptide Fragments; D011135:Polysaccharides, Bacterial; D015922:Complement C1q; D003094:Collagen